Liquid biopsy and multiparametric analysis in management of liver malignancies: new concepts of the patient stratification and prognostic approach

Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma

(2018) Xiao-Lu Ma et al.   ANNALS OF SURGICAL ONCOLOGY

Capacity to report on mortality attributable to chronic hepatitis B and C infections by Member States: An exercise to monitor progress towards viral hepatitis elimination

(2018) G. Duarte et al.   JOURNAL OF VIRAL HEPATITIS

Protein S100-A8: A potential metastasis-associated protein for breast cancer determined via iTRAQ quantitative proteomic and clinicopathological analysis

(2018) Jing‑Min Zhong et al.   Oncology Letters

Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization

(2017) Hujia Shen et al.   MEDICINE

Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients

(2017) Xiang Zhang et al.   MEDICINE

Factors Associated with Early Mortality Among Patients with De Novo Metastatic Breast Cancer: A Population‐Based Study

(2017) Ines Vaz‐Luis et al.   ONCOLOGIST

Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy

(2017) Hanna-Riikka Teppo et al.   Oxidative Medicine and Cellular Longevity

Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma

(2017) Ying-Fen Hong et al.   Oncology Letters

Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification?

(2017) Olga Golubnitschaja   EPMA Journal

Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon?

(2017) Jiri Polivka et al.   EPMA Journal

Breast cancer risk assessment: a non-invasive multiparametric approach to stratify patients by MMP-9 serum activity and RhoA expression patterns in circulating leucocytes

(2016) Olga Golubnitschaja et al.   AMINO ACIDS

Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours

(2016) Olga Golubnitschaja et al.   BMC CANCER

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cellular Distribution and Gene Expression Pattern of Metastasin (S100A4), Calgranulin A (S100A8), and Calgranulin B (S100A9) in Oral Lesions as Markers for Molecular Pathology

(2016) Jan Reckenbeil et al.   CANCER INVESTIGATION

Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes

(2016) Olga Golubnitschaja et al.   CLINICAL & EXPERIMENTAL METASTASIS

Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization

(2016) Takeshi Ichikawa et al.   ONCOLOGY

S100A8 facilitates the migration of colorectal cancer cells through regulating macrophages in the inflammatory microenvironment

(2016) HE ZHA et al.   ONCOLOGY REPORTS

Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures

(2016) Olga Golubnitschaja et al.   TUMOR BIOLOGY

Advances in Local and Systemic Therapies for Hepatocellular Cancer

(2016) Ali A. Mokdad et al.   Current Oncology Reports

SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells

(2016) Stefania Moz et al.   Oncotarget

Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016

(2016) Olga Golubnitschaja et al.   EPMA Journal

Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy

(2015) Cigdem Soydal et al.   ANNALS OF NUCLEAR MEDICINE

Molecular Links between Alcohol and Tobacco Induced DNA Damage, Gene Polymorphisms and Patho-physiological Consequences: A Systematic Review of Hepatic Carcinogenesis

(2015) Abdul Anvesh Mansoori et al.   Asian Pacific Journal of Cancer Prevention

Blood reflects tissue oxidative stress: a systematic review

(2015) Nikos V. Margaritelis et al.   BIOMARKERS

A pro-tumorigenic function of S100A8/A9 in carcinogen-induced hepatocellular carcinoma

(2015) Aurora De Ponti et al.   CANCER LETTERS

Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization

(2015) Soon Sun Kim et al.   CYTOKINE

The Global Burden of Cancer 2013

(2015) Christina Fitzmaurice et al.   JAMA Oncology

EPMA position paper in cancer: current overview and future perspectives

(2015) Godfrey Grech et al.   EPMA Journal

Involvement of DNA Damage Response Pathways in Hepatocellular Carcinoma

(2014) Sheau-Fang Yang et al.   Biomed Research International

Oxidative Stress and Epigenetic Instability in Human Hepatocarcinogenesis

(2013) Naoshi Nishida et al.   DIGESTIVE DISEASES

Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo

(2012) R. Coriat et al.   MOLECULAR CANCER THERAPEUTICS

Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview

(2011) Monica Marra et al.   Journal of Translational Medicine

S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis

(2009) Julia Németh et al.   HEPATOLOGY

S100A8 and S100A9 Overexpression Is Associated with Poor Pathological Parameters in Invasive Ductal Carcinoma of the Breast

(2008) Kazumori Arai et al.   CURRENT CANCER DRUG TARGETS